Q2 2018 Holdings
Filed 2018-08-14 | 119 holdings | $3.4B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Momenta Pharmaceuticals, Inc.(MNTA) | COM | 60877T100 | $6.3K | 308,500 | 0.0% |
| G1 Therapeutics, Inc.(GTHXEUR) | COM | 3621LQ109 | $7.4K | 169,492 | 0.0% |
| Foamix Pharmaceuticals Ltd. | SHS | M46135105 | $7.5K | 1,490,201 | 0.0% |
| Galmed Pharmaceuticals Ltd.(GLMD) | SHS | M47238106 | $7.6K | 636,140 | 0.0% |
| Progenics Pharmaceuticals, Inc. | COM | 743187106 | $7.9K | 979,016 | 0.0% |
| Acceleron Pharma Inc.(XLRN) | COM | 00434H108 | $8.0K | 163,900 | 0.0% |
| InflaRx N.V.(IFRX) | COM | N44821101 | $8.3K | 258,824 | 0.0% |
| Albireo Pharma, Inc.(BDQM) | COM | 01345P106 | $8.9K | 250,000 | 0.0% |
| Corsicanto II Designated Activity Company | NOTE 3.5% 1/5/2047 | 220485AB2 | $10.9K | $10,000,000 | 0.0% |
| Exelixis, Inc.(EXEL) | COM | 30161Q104 | $11.0K | 513,410 | 0.0% |
| BioMarin Pharmaceutical Inc. | NOTE 0.75% 10/15/2018 | 09061GAE1 | $13.0K | $12,228,000 | 0.0% |
| Neurocrine Biosciences, Inc. | NOTE 2.25% 5/15/2024 | 64125CAD1 | $14.5K | $10,000,000 | 0.0% |
| Aeglea BioTherapeutics, Inc.(AGLEUSD) | COM | 00773J103 | $14.7K | 1,387,872 | 0.0% |
| Intellia Therapeutics, Inc.(NTLA) | COM | 45826J105 | $15.0K | 546,922 | 0.0% |
| Audentes Therapeutics, Inc.(BOLDEUR) | COM | 05070R104 | $15.0K | 393,222 | 0.0% |
| BioMarin Pharmaceutical Inc. | NOTE 0.599% 8/1/2024 | 09061GAH4 | $15.2K | $15,000,000 | 0.0% |
| Clementia Pharmaceuticals Inc. | COM | 185575107 | $15.7K | 1,192,595 | 0.0% |
| ContraFect Corporation(CFRXEUR) | COM | 212326102 | $15.8K | 7,153,076 | 0.0% |
| Insmed Incorporated(INSM) | COM PAR $.01 | 457669307 | $16.6K | 700,000 | 0.0% |
| Aimmune Therapeutics, Inc.(AIMT) | COM | 00900T107 | $18.1K | 673,908 | 0.0% |
| Sangamo Therapeutics, Inc.(SGMO) | COM | 800677106 | $18.2K | 1,283,923 | 0.0% |
| Zymeworks Inc. | COM | 98985W102 | $19.4K | 1,311,085 | 0.0% |
| Solid Biosciences Inc. | COM | 83422E105 | $20.9K | 587,884 | 0.0% |
| MyoKardia, Inc. | COM | 62857M105 | $21.5K | 433,121 | 0.0% |
| Halozyme Therapeutics, Inc.(HALO) | COM | 40637H109 | $21.7K | 1,283,929 | 0.0% |
| uniQure N.V.(QURE) | SHS | N90064101 | $22.9K | 605,000 | 0.0% |
| Galapagos NV(GLPG) | SPONSORED ADR | 36315X101 | $24.0K | 259,894 | 0.0% |
| Merus N.V. | COM | N5749R100 | $26.4K | 1,160,014 | 0.0% |
| Aquinox Pharmaceuticals, Inc. | COM | 03842B101 | $29.0K | 10,934,154 | 0.0% |
| Bellicum Pharmaceuticals, Inc. | COM | 079481107 | $30.2K | 4,093,447 | 0.0% |
| bluebird bio, Inc. | COM | 09609G100 | $31.4K | 200,000 | 0.0% |
| Endocyte, Inc. | COM | 29269A102 | $31.4K | 2,277,799 | 0.0% |
| Xencor, Inc.(XNCR) | COM | 98401F105 | $32.3K | 872,072 | 0.0% |
| Erytech Pharma S.A. | SPONSORED ADR | 29604W108 | $34.5K | 3,085,969 | 0.0% |
| Abeona Therapeutics Inc.(ABEO1EUR) | COM | 00289Y107 | $35.0K | 2,184,364 | 0.0% |
| Novavax, Inc. | NOTE 3.75% 2/1/23 | 670002AB0 | $42.7K | $73,500,000 | 0.0% |
| GW Pharmaceuticals plc | ADS | 36197T103 | $44.9K | 321,800 | 0.0% |
| Tricida, Inc.(1T7) | COM | 89610F101 | $47.8K | 1,600,000 | 0.0% |
| Idera Pharmaceuticals, Inc. | COM NEW | 45168K405 | $51.0K | 38,654,811 | 0.0% |
| Kiniksa Pharmaceuticals, Ltd. | COM CL A | G5269C101 | $52.1K | 3,000,000 | 0.0% |
| Invitae Corporation(NVTA1EUR) | COM | 46185L103 | $61.7K | 8,399,411 | 0.0% |
| CymaBay Therapeutics, Inc.(CBAYUSD) | COM | 23257D103 | $66.0K | 4,917,700 | 0.0% |
| Amarin Corporation plc | SPONSORED ADR NEW | 023111206 | $70.0K | 22,669,509 | 0.0% |
| Rhythm Pharmaceuticals, Inc.(RYTM) | COM | 76243J105 | $84.7K | 2,708,200 | 0.0% |
| Neurocrine Biosciences, Inc.(NBIX) | COM | 64125C109 | $92.8K | 944,624 | 0.0% |
| Array BioPharma Inc.(ARRYEUR) | COM | 04269X105 | $94.9K | 5,656,196 | 0.0% |
| Sage Therapeutics, Inc.(SG7) | COM | 78667J108 | $96.0K | 613,300 | 0.0% |
| DBV Technologies S.A. | SPONSORED ADR | 23306J101 | $106.3K | 5,509,560 | 0.0% |
| Spark Therapeutics, Inc. | COM | 84652J103 | $114.6K | 1,384,130 | 0.0% |
| Mirati Therapeutics, Inc.(MRTXEUR) | COM | 60468T105 | $123.9K | 2,513,462 | 0.0% |